
Over five months, Adta contributed to the trifork/fmk-schemas repository by delivering seven schema-driven features focused on improving data model clarity, API contract reliability, and documentation. Adta refined dosage and treatment structures, enhanced consent management, and standardized naming conventions to reduce ambiguity and streamline downstream integrations. Using Java, TypeScript, and XML Schema, Adta implemented changes such as introducing the DosagePeriod structure, renaming fields for semantic accuracy, and updating WSDL operations for consistency. The work emphasized maintainability and data integrity, with thorough documentation and precise commit traceability, enabling faster onboarding and more robust integrations without introducing new bugs during the period.
Month: 2026-04 – Focused on data-model clarity and documentation improvements in trifork/fmk-schemas. Delivered the PRNTrigger rename in Precondition schema and updated documentation to reflect the new field purpose, improving data accuracy and downstream integration reliability, with clear change traceability.
Month: 2026-04 – Focused on data-model clarity and documentation improvements in trifork/fmk-schemas. Delivered the PRNTrigger rename in Precondition schema and updated documentation to reflect the new field purpose, improving data accuracy and downstream integration reliability, with clear change traceability.
Month: 2026-03 — Delivered two schema-focused features for trifork/fmk-schemas that strengthen data contracts, auditability, and documentation. (1) Consent Management Improvements standardize the drugmedication ID across GiveConsentRequest and RemoveConsentRequest and extend NegativeConsent with a ReportedBy field and a removal flag to improve change tracking. (2) Dosage Period Refactor and Documentation introduce a DosagePeriod structure for empty/unspecified dosages and update documentation to clarify Empty vs Unspecified usage. These changes reduce reconciliation risk, improve governance, and accelerate developer onboarding for integrations. Demonstrated technologies and skills include schema evolution, API contract discipline, data modeling clarity, and thorough documentation.
Month: 2026-03 — Delivered two schema-focused features for trifork/fmk-schemas that strengthen data contracts, auditability, and documentation. (1) Consent Management Improvements standardize the drugmedication ID across GiveConsentRequest and RemoveConsentRequest and extend NegativeConsent with a ReportedBy field and a removal flag to improve change tracking. (2) Dosage Period Refactor and Documentation introduce a DosagePeriod structure for empty/unspecified dosages and update documentation to clarify Empty vs Unspecified usage. These changes reduce reconciliation risk, improve governance, and accelerate developer onboarding for integrations. Demonstrated technologies and skills include schema evolution, API contract discipline, data modeling clarity, and thorough documentation.
In February 2026, the trifork/fmk-schemas repository delivered two key schema improvements that strengthen API clarity, contract reliability, and data integrity. The work focused on API naming consistency, WSDL clarity, and ActivePeriod data handling, delivering tangible business value through improved developer experience and more robust integrations.
In February 2026, the trifork/fmk-schemas repository delivered two key schema improvements that strengthen API clarity, contract reliability, and data integrity. The work focused on API naming consistency, WSDL clarity, and ActivePeriod data handling, delivering tangible business value through improved developer experience and more robust integrations.
Month: 2026-01 — Data Model Cleanup for trifork/fmk-schemas delivering a leaner, more coherent dosage/type treatment structure. Key changes include removing PN-kur from PredefinedProfileCodeDosageTypeEnumeration and renaming PRNFixed to EpisodicTreatment, with the latter moved under Precondition to reflect updated treatment semantics. These changes reduce schema complexity, prevent semantic drift, and lay groundwork for simpler downstream tooling and feature expansions. No explicit bug fixes were logged this month; primary focus was on data-model hygiene and maintainability.
Month: 2026-01 — Data Model Cleanup for trifork/fmk-schemas delivering a leaner, more coherent dosage/type treatment structure. Key changes include removing PN-kur from PredefinedProfileCodeDosageTypeEnumeration and renaming PRNFixed to EpisodicTreatment, with the latter moved under Precondition to reflect updated treatment semantics. These changes reduce schema complexity, prevent semantic drift, and lay groundwork for simpler downstream tooling and feature expansions. No explicit bug fixes were logged this month; primary focus was on data-model hygiene and maintainability.
December 2025: Delivered targeted dosage data model improvements in trifork/fmk-schemas to improve data accuracy, support self-administration, and enhance PRN handling. No major bugs fixed this month. The changes reduce maintenance burden and improve downstream interoperability through refactoring and clearer API contracts.
December 2025: Delivered targeted dosage data model improvements in trifork/fmk-schemas to improve data accuracy, support self-administration, and enhance PRN handling. No major bugs fixed this month. The changes reduce maintenance burden and improve downstream interoperability through refactoring and clearer API contracts.

Overview of all repositories you've contributed to across your timeline